← Back to Clinical Trials
Recruiting NCT04461301

NCT04461301 Multimodal Prehabilitation for Surgery in the Elderly: a Randomised, Prospective, Multicenter, Multidisciplinary Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04461301
Status Recruiting
Phase
Sponsor Insel Gruppe AG, University Hospital Bern
Condition Frail Elderly Syndrome
Study Type INTERVENTIONAL
Enrollment 466 participants
Start Date 2022-02-01
Primary Completion 2026-07-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Multimodal Prehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 466 participants in total. It began in 2022-02-01 with a primary completion date of 2026-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This multicentric, randomised controlled trial is to the investigators knowledge the first implementation of a multimodal, multidisciplinary prehabilitation approach using knowledge from different specialties to lower complications and to increase cost effectiveness after major surgery in elderly, frail patients.

Eligibility Criteria

Inclusion Criteria: * Written informed consent * comorbid (≥ASA 3) * pre-existing fitness deficit: AT\<11ml/kg/min respectively VO2peak\<14ml/kg/min if AT unavailable or VE/VCO2 slope \> 33 * scheduled for major urologic, thoracic, visceral, orthopaedic or cardiovascular surgery * screening at least 2 weeks prior to surgery Exclusion Criteria: * Paralysis or patients with mobility problems (who are unable to exercise), * Premorbid conditions or orthopaedic impairments that contraindicate exercise, * Cognitive disabilities, * Chronic renal failure (need for dialysis) * Emergency procedures.

Contact & Investigator

Central Contact

Dominique A Engel, Dr

✉ dominique.engel@insel.ch

📞 0041316322111

Principal Investigator

Dominique A Engel, Dr

PRINCIPAL INVESTIGATOR

Department of Anaesthesiology and Pain Therapy, University Hospital Bern

Frequently Asked Questions

Who can join the NCT04461301 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Frail Elderly Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04461301 currently recruiting?

Yes, NCT04461301 is actively recruiting participants. Contact the research team at dominique.engel@insel.ch for enrollment information.

Where is the NCT04461301 trial being conducted?

This trial is being conducted at Bern, Switzerland.

Who is sponsoring the NCT04461301 clinical trial?

NCT04461301 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Dominique A Engel, Dr at Department of Anaesthesiology and Pain Therapy, University Hospital Bern. The trial plans to enroll 466 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology